MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D Efforts

NEXT STORY
GigaGen Announces Publication of Research Describing a New Class of Drugs, Recombinant Hyperimmunes, Including its Novel COVID-19 Therapy, GIGA-2050
PREV STORY
Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema

- ADVM-053 is a novel gene therapy candidate designed as a potential single‑administration treatment ...

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman

author_avatar
NASDAQ Market News

NewYork-Presbyterian Named New York’s #1 Hospital in U.S. News & World Report’s ‘Best Hospitals’ for the 17th Year in a Row

New York, New York, Aug. 08, 2017 (GLOBE NEWSWIRE) -- NewYork-Presbyterian Hospital, one of ...

author_avatar
NASDAQ Market News